title: [Enterosorption in the treatment of patients with chronic urticaria].
abstract: A synthetic carbon sorbent (SKNP-2) was included in the treatment of 197 patients with relapsing urticaria. Courses lasted 7, 14, 20 days. The clinical effect was favourable and its efficacy increased with prolongation of the therapy course time using the enterosorbent. Immunological parameters did not change in the course of treatment.
authors.forename: L P
authors.initials: LP
authors.lastname: Bobkova
authors.forename: V A
authors.initials: VA
authors.lastname: Beĭko
authors.forename: P V
authors.initials: PV
authors.lastname: Grishilo
authors.forename: A V
authors.initials: AV
authors.lastname: Shevchuk
authors.forename: V V
authors.initials: VV
authors.lastname: Glinskiĭ
authors.forename: S V
authors.initials: SV
authors.lastname: Mikhalovskiĭ
authors.forename: V V
authors.initials: VV
authors.lastname: Strelko
authors.forename: N M
authors.initials: NM
authors.lastname: Berezhnaia
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003131:Combined Modality Therapy; D016061:Enterosorption / Q000379:methods*; D005069:Evaluation Studies as Topic; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008875:Middle Aged; D012008:Recurrence; D014581:Urticaria / Q000276:immunology / Q000628:therapy*
chemical_list: D007136:Immunoglobulins
vernacular_title: Enterosorbtsiia v lechenii bol'nykh khronicheskoĭ krapivnitseĭ.